ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
NexGel Inc

NexGel Inc (NXGL)

3.30
0.00
( 0.00% )
Updated: 10:14:25

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.30
Bid
3.14
Ask
3.31
Volume
19,883
3.25 Day's Range 3.3958
1.7107 52 Week Range 3.55
Market Cap
Previous Close
3.30
Open
3.26
Last Trade
705
@
3.3
Last Trade Time
10:14:10
Financial Volume
$ 66,462
VWAP
3.3427
Average Volume (3m)
59,927
Shares Outstanding
6,790,777
Dividend Yield
-
PE Ratio
-7.10
Earnings Per Share (EPS)
-0.46
Revenue
4.09M
Net Profit
-3.16M

About NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels a... NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. The company recognizes revenue from contract manufacturing. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
NexGel Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NXGL. The last closing price for NexGel was $3.30. Over the last year, NexGel shares have traded in a share price range of $ 1.7107 to $ 3.55.

NexGel currently has 6,790,777 shares outstanding. The market capitalization of NexGel is $22.41 million. NexGel has a price to earnings ratio (PE ratio) of -7.10.

NXGL Latest News

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Quarterly revenue growth driven by a sequential increase of 99% in branded consumer products and 103% in contract manufacturing Gross profit margin for the quarter was 43.6% compared to 28.2% in...

NEXGEL Announces $2,000,000 Registered Direct Offering

LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...

NEXGEL to Participate in Upcoming October Investor Conferences

LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially

LANGHORNE, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection

LANGHORNE, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), leading provider of medical and over-the-counter (OTC) products including...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-0.6024096385543.323.422.9501842333.19638064CS
40.28549.467259337893.01463.552.671015023.14580193CS
120.4415.38461538462.863.552.4599273.00299773CS
260.9439.83050847462.363.551.84513862.84357653CS
521.4679.3478260871.843.551.7107355212.72964549CS
156-1.1-254.44.661.09716472.57834457CS
260-1.1-254.44.661.09716472.57834457CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
$ 2.235
(128.06%)
86.61M
SKKSKK Holdings Limited
$ 9.42
(106.58%)
3.18M
CRNCCerence Inc
$ 5.0582
(79.37%)
12.46M
SPAISafe Pro Group Inc
$ 4.41
(37.81%)
35.54M
CDTConduit Pharmaceuticals Inc
$ 0.1236
(33.91%)
425.15M
PYXSPyxis Oncology Inc
$ 2.0684
(-45.85%)
7.03M
KURAKura Oncology Inc
$ 10.0068
(-37.10%)
5.74M
SHOTWSafety Shot Inc
$ 0.1001
(-33.27%)
2.5k
AGFYAgrify Corporation
$ 25.95
(-33.05%)
295.62k
BLRXBioLineRx Ltd
$ 0.3717
(-31.82%)
4.77M
CDTConduit Pharmaceuticals Inc
$ 0.1228
(33.04%)
425.18M
AKTSAkoustis Technologies Inc
$ 0.0979
(12.40%)
165.19M
NVDANVIDIA Corporation
$ 144.86
(-0.71%)
140.13M
WORXSCWorx Corporation
$ 2.24
(128.57%)
86.64M
ELABElevai Labs Inc
$ 0.02035
(-4.91%)
77.43M

NXGL Discussion

View Posts
TrendTrade2016 TrendTrade2016 1 week ago
NXGL...MY NEXT BIO BEAST READY TO ROAR THROUGH WALL STREET
👍️0
Monksdream Monksdream 2 weeks ago
NXGL, new 52 week high
👍️0
81vette 81vette 1 month ago
Looks like flipping the warrents would have been good last few days
👍️0
Helter Skelter Helter Skelter 1 month ago
Expecting earnings report around Nov 14th...🤪
👍️0
Helter Skelter Helter Skelter 1 month ago
Hey 81vette, expecting earnings' NEWS any moment/day.
Also anticipating a PROFIT which should send $NXGL, I'm thinking...😺
👍️0
81vette 81vette 1 month ago
Hey bro,good to see you,yes it’s been stairstepping up nicely since early 2023
Thanks for reminding me about it!!
👍️0
Helter Skelter Helter Skelter 1 month ago
Looking for 100% gain from here (2.80) when earnings are released around Nov. 14, 2024.

As of August 13, 2024, the registrant had 6,324,266 shares of common stock outstanding.



$NXGL



👉️ NXGL 10Q Period Ending June 30, 2024
👍️0
Monksdream Monksdream 5 months ago
NXGL under $3
👍️0
tdag910 tdag910 9 months ago
Winner winner chicken dinner!!
👍️0
Pinksatthehotel Pinksatthehotel 9 months ago
Looking good!
👍️0
tdag910 tdag910 1 year ago
Anybody home?
👍️0
alyck alyck 1 year ago
NXGL looking great! Solidly over $2 and volume increasing. Keep it going
👍️0
81vette 81vette 2 years ago
Ended @New 52 week high,blue sky babe!! Enjoy the weekend everyone!!
👍️0
81vette 81vette 2 years ago
contracts with pro sports teams will make brand huge,building a great company,investment in packaging plant was wise
👍️0
81vette 81vette 2 years ago
For the first quarter of 2023, revenue totaled $620 thousand and increased by $224 thousand, or 56.6%, compared to $396 thousand for the same period the year prior. The increase in overall revenues was primarily due to sales growth in both contract manufacturing and branded products. Revenue during the first quarter of 2023 includes one full month of revenue contribution from the Company’s newly formed joint venture with C.G. Laboratories.first quarter we delivered 56.6% revenue growth year-over-year, driven by increased sales in contract manufacturing and branded consumer products. We also started to see contribution in March from our new joint venture with CG Labs. During the quarter, we launched several new products and invested strategically in sales and marketing to support those launches. We are already starting to see the financial returns from these investments in the second quarter, as well as from our new JV.” “Based on the dynamic changes to our business, which include the March 1 joint venture, I feel it’s important to provide a one-time exception to our policy of not providing guidance. Based on these developments and our progress to date, we are projecting $1.0 million in revenue for the second quarter of 2023, an increase of 78.2% year-over-year. Complementing this, we had approximately $5.8 million in cash and cash equivalents at quarter-end, which gives us sufficient runway to operate and the ability to be opportunistic about further potential investments to accelerate our growth.”Acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business.
Executed a supply agreement with a large new customer relating to a new consumer product.Launched advertising and marketing initiative, which has increased branded product sales.
👍️ 1
81vette 81vette 2 years ago
watch demand,next move up thru 52 week high,very low supply atm
👍️0
81vette 81vette 2 years ago
GOLDEN CROSS is best indicator of long bulls,follow the money is the saying
👍️0
81vette 81vette 2 years ago
eps q/q up 60%,is why moving up,big profit coming,great future $ deals,expect institutions loading long,way undervalued@ 10M mkt cap
👍️0
81vette 81vette 2 years ago
GOLDEN CROSS now,thru triple top res.,52week high>$2.00,then blue sky
👍️0
81vette 81vette 2 years ago
4M float,5M o/s,.52%short,buy vol 15X ave,not optionable,shares borrow ava. dropped 400% with pre-mkt volume,easily could go ZERO BORROW with this low float/os
👍️0